Neo-POLEM, NCT06692959: A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer |
|
|
| Not yet recruiting | 2 | 44 | Europe | PD-1 vaccine IMU-201 (PD1-Vaxx) | University of Southampton, Australasian Gastro-Intestinal Trials Group | Colorectal Cancer | 08/26 | 06/28 | | |
IMPRINTER, NCT04432207: A Study of IMU-201 (PD1-Vaxx), a B-Cell Immunotherapy, in Adults with Non-Small Cell Lung Cancer |
|
|
| Active, not recruiting | 1 | 24 | US, RoW | IMU-201 (administered as PD1-Vaxx) - Regimen 1, PD1-Vaxx, APi2568, IMU-201 (administered as PD1-Vaxx) - Regimen 2, IMU-201 (administered as PD1-Vaxx) - Regimen 3, Atezolizumab, TECENTRIQ, Standard of care chemotherapy | Imugene Limited | Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, Non-small Cell Lung Cancer Stage IV, Squamous Non-small-cell Lung Cancer, Large Cell Carcinoma Lung, Adenocarcinoma Lung | 11/24 | 05/25 | | |
